Connecting Radiology | Enabling collaboration and professional development
Nuclear medicine from Becquerel to the present.
Graham LS, Kereiakes JG, Harris C, Cohen MB.
VA Medical Center/UCLA, Nuclear Medical Service, Sepulveda 91343.
Radiographics. 1989 Nov;9(6):1189-202
During a period of a little over ninety years, the use of radioactive materials has moved from the discovery of natural radioactivity by Becquerel to the use of highly sophisticated equipment for in-house production of biologically important molecules labeled with radionuclides, for the measurement of body functions. Radiation detectors have progressed from photographic plates and the gold leaf electroscope to the routine use of improved scintillation detectors for imaging the three-dimensional distribution of radioactive materials in the body as a function of space and time. It is expected that future improvements will be along the line of instruments with better spatial resolution, contrast, and sensitivity. Advances in hardware and software will be more than matched by developments in radiopharmaceuticals, including the use of monoclonal antibodies and receptor mapping agents which promise the exquisite specificity and sensitivity of radioimmunoassay procedures.
Posted via PubMed for educational and discussion purposes only.
Link to PubMed Reference
VA Medical Center/UCLA, Nuclear Medical Service, Sepulveda 91343.
Radiographics. 1989 Nov;9(6):1189-202
During a period of a little over ninety years, the use of radioactive materials has moved from the discovery of natural radioactivity by Becquerel to the use of highly sophisticated equipment for in-house production of biologically important molecules labeled with radionuclides, for the measurement of body functions. Radiation detectors have progressed from photographic plates and the gold leaf electroscope to the routine use of improved scintillation detectors for imaging the three-dimensional distribution of radioactive materials in the body as a function of space and time. It is expected that future improvements will be along the line of instruments with better spatial resolution, contrast, and sensitivity. Advances in hardware and software will be more than matched by developments in radiopharmaceuticals, including the use of monoclonal antibodies and receptor mapping agents which promise the exquisite specificity and sensitivity of radioimmunoassay procedures.
Posted via PubMed for educational and discussion purposes only.
Link to PubMed Reference
Views: 2
© 2024 Created by radRounds Radiology Network.
Powered by
